En Es

Industry News

Global PCR and Real-Time PCR Testing Market Driven by Need for Early Disease Detection

By Labmedica International staff writers
09 Sep 2022

Image: The global PCR and real-time PCR testing market is expected to approach USD 25 billion in 2026 (Photo courtesy of Pexels)

The polymerase chain reaction (PCR) and real-time polymerase chain reaction testing market consists of sales of PCR and real-time PCR testing services and related products. The real-time RT-PCR technique is a highly sensitive and specific testing method that can deliver a reliable diagnosis in as fast as three hours, unlike the other laboratory tests that take an average of 6 to 8 hours. Real-time RT-PCR is significantly faster and has a lower potential for contamination or errors as the entire process is within a closed tube. With the onset of chronic diseases, there is focus on detecting the cause of the disease to decrease its onset on people, for drug discovery and for starting the appropriate treatment at the appropriate time, which enables faster cure, saves maximum lives and decreases after-effects.

Early detection plays a key role in treating COVID-19 patients. Real-time RT-PCR is considered to be the most accurate method available for the detection of coronavirus. The RT-PCR test is the standard test for coronavirus and is used for its high sensitivity, which enables it to detect early infection. This has created a huge demand for PCR testing kits. Thus, the need for early detection of COVID-19 is driving the growth of the PCR and real-time PCR testing market. Additionally, most companies are coming up with real-time RT-PCR tests for coronavirus, thus contributing to the market growth. The global PCR and real time PCR testing market is expected to grow at a CAGR of 6.2% from USD 18.5 billion in 2021 to USD 19.64 billion in 2022 and further grow to USD 24.61 billion in 2026 at a CAGR of 5.8%. In 2021, Asia Pacific was the largest PCR and real-time PCR testing market, followed by Western Europe.

These are the latest findings of Research and Markets (Dublin, Ireland), a market research firm.

The players operating in the PCR and real-time PCR testing market manufacture, develop, or deploy related devices, reagents, and services, to detect and measure DNA (or RNA) in a sample. PCR and real-time PCR testing find applications in cloning, genotyping, mutation testing, paternity testing, sequencing, and microarrays. The main products involved in PCR and real-time PCR testing are consumables and reagents, instruments, and software and services. The technologies involved in PCR and real-time PCR testing are quantitative PCR and digital PCR that find various applications such as clinical diagnostics, life science research, industrial applications, and others. The need for early detection of diseases is expected to continue driving the global PCR and real time PCR testing market. The players operating in the PCR and RT PCR testing market are coming up with new test kits and systems for the diagnosis of diseases. However, the development of alternative technologies such as CRISPR is expected to hinder market growth.

Related Links:
Research and Markets 

E-mail Print
FaceBook Twitter Google+ Linked in

Additional news

23 Nov 2022
Global Visualization Instruments for MIS Market Driven by Increasing Demand for Endoscopy Procedures
The increasing demand for visualization systems for complex surgical procedures, growing demand for minimally invasive surgeries, and rising prevalence of chronic diseases are expected to help the global visualization instruments for minimally invasive surgery (MIS) market register a CAGR of 7.2% between 2022 and 2031 and reach a value of USD 21 billion by 2031.
Read More
11 Nov 2022
Global Diagnostic ECG Market Driven by Increased Incidence of Cardiac Diseases
The rising prevalence of such chronic conditions is necessitating the need for diagnosis and treatment in order to keep track of the patient's daily medical condition and maintain medical records. This, coupled with rising hospitalization of the older population for the treatment of cardiac diseases, has increased the need for electrocardiograph (ECG) diagnosis.
Read More
11 Nov 2022
Radcal to Supply Quality Assurance X-Ray Testing Equipment to West Physics
Radcal Corporation (Monrovia, CA, USA), a leading manufacturer of diagnostic X-ray quality assurance (QA) meters, has reached an agreement with West Physics (Atlanta, GA, USA), one of the largest and most successful Medical Physics groups in the U.S., to supply QA X-ray testing equipment.
Read More
09 Nov 2022
Leica Biosystems Acquires Cell IDx, Expanding Offerings in Multiplexed Tissue Profiling
Leica Biosystems, a technology leader in automated staining and brightfield and fluorescent imaging (Nussloch, Germany), has acquired Cell IDx, Inc. (San Diego, CA, USA), which provides multiplex staining panels, tissue staining, and imaging and analysis services.
Read More
08 Nov 2022
Global Infusion Pumps Market Driven by Increasing Incidence of Chronic Diseases
Rising demand for ambulatory infusion pumps in home care, increasing incidence of chronic diseases along with a rapid growth of the geriatric population, and growing number of surgical procedures being performed, are driving the growth of the global infusion pumps market. As a result, the market is projected to register a CAGR of 7% from USD 14.7 billion in 2022 to USD 20.5 billion by 2027.
Read More
07 Nov 2022
Mast Group Enters into Multi-Country Distribution Agreement for Nanomix's eLab System
Mast Group Limited (Liverpool, UK) and Nanomix (Emeryville, CA, USA) have entered into a multi-region distribution agreement wherein Mast will market and distribute the Nan?mix eLab system in the UK, Germany, France, Ireland and South Africa.
Read More
07 Nov 2022
AI-Enabled Diagnostic Testing Could Become More Accurate and Reliable than Current Tests
An expanded collaboration between two industry leaders will pave the way for the development of AI-enabled diagnostic testing that is more accurate and reliable than current U.S. tests for patients with chronic diseases, including kidney, cardiovascular, liver and neurologic conditions.
Read More
01 Nov 2022
Global Infectious Respiratory Disease Diagnostics Market Driven by New Multiplex PCR Tests and POC Products
The global infectious respiratory disease diagnostics market size is expected to reach USD 43.6 billion by 2030, driven by an increase in the prevalence of infectious respiratory diseases and initiatives taken by governments & non-profit organizations to introduce novel & innovative products to address the growing demand.
Read More
01 Nov 2022
Johnson & Johnson to Acquire Cardiovascular Technology Company Abiomed in USD 16.6 Billion Deal
Johnson & Johnson (New Brunswick, N.J., USA) has entered into a definitive agreement to acquire all outstanding shares of Abiomed, Inc. (Danvers, MA, USA) in a deal valued at approximately USD 16.6 billion which includes cash acquired.
Read More
Copyright © 2000-2022 TradeMed.com. All rights reserved. | Terms And Conditions